-
161.
公开(公告)号:NZ253121A
公开(公告)日:1995-12-21
申请号:NZ25312193
申请日:1993-06-08
Applicant: BASF AG
Inventor: STEINER GERD , UNGER LILIANE , BEHL BERTHOLD , TESCHENDORF HANS-JUERGEN , MUNSCHAUER RAINER
IPC: A61K20060101 , A61K31/33 , A61K31/395 , A61K31/40 , A61K31/4045 , A61K31/4184 , A61K31/505 , C07D513/04 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/54 , A61K31/542 , A61P25/00 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D20060101 , C07D207/00 , C07D209/02 , C07D209/52 , C07D221/00 , C07D239/00 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/00 , C07D403/04 , C07D403/06 , C07D403/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.
-
公开(公告)号:CZ144895A3
公开(公告)日:1995-12-13
申请号:CZ144895
申请日:1993-12-06
Applicant: BASF AG
Inventor: SCHLECKER RAINER , TREIBER HANS-JORG , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: C07D487/04 , A61K31/505 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/28
Abstract: PCT No. PCT/EP93/03424 Sec. 371 Date May 12, 1995 Sec. 102(e) Date May 12, 1995 PCT Filed Dec. 6, 1993 PCT Pub. No. WO94/13294 PCT Pub. Date Jul. 23, 1994The use of triazoloquinazolines for the production of drugs for controlling central nervous disorders is described. The triazoloquinazolines have the formula (I) where R1, R2 and X have the meanings stated in the description.
-
公开(公告)号:ZA942246B
公开(公告)日:1995-10-02
申请号:ZA942246
申请日:1994-03-30
Applicant: BASF AG
Inventor: TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , C07D233/61 , C07D487/04 , C07D , A61K
-
公开(公告)号:NO953892L
公开(公告)日:1995-09-29
申请号:NO953892
申请日:1995-09-29
Applicant: BASF AG
Inventor: TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/24 , A61P25/26 , C07D235/00 , C07D241/00 , C07D487/04
-
公开(公告)号:NO953892D0
公开(公告)日:1995-09-29
申请号:NO953892
申请日:1995-09-29
Applicant: BASF AG
Inventor: TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/24 , A61P25/26 , C07D235/00 , C07D241/00 , C07D487/04
-
公开(公告)号:NO953892A
公开(公告)日:1995-09-29
申请号:NO953892
申请日:1995-09-29
Applicant: BASF AG
Inventor: TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/24 , A61P25/26 , C07D235/00 , C07D241/00 , C07D487/04
CPC classification number: C07D487/04
-
公开(公告)号:FI954614A
公开(公告)日:1995-09-28
申请号:FI954614
申请日:1995-09-28
Applicant: BASF AG
Inventor: TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS-PETER
IPC: A61K31/495 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/24 , A61P25/26 , C07D235/00 , C07D241/00 , C07D487/04 , C07D
-
公开(公告)号:HU9501691D0
公开(公告)日:1995-08-28
申请号:HU9501691
申请日:1993-11-27
Applicant: BASF AG
Inventor: BEHL BERTHOLD , SCHLECKER RAINER , TREIBER HANS-JOERG , HOFMANN HANS PETER
IPC: A61K31/505 , A61P25/02 , A61P25/20 , C07D487/04
Abstract: PCT No. PCT/EP93/03331 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Nov. 27, 1993 PCT Pub. No. WO94/13672 PCT Pub. Date Jun. 23, 1994Novel triazoloquinazolines of the formula I gs stated in the description, and their preparation are described. The compounds are suitable for controlling diseases.
-
公开(公告)号:BR9305090A
公开(公告)日:1995-08-08
申请号:BR9305090
申请日:1993-12-16
Applicant: BASF AG
Inventor: STEINER GERD , UNGER LILIANE , BEHL BERTHOLD , TESCHENDORF HANS-JUERGEN
IPC: A61K31/40 , C07D209/94
-
公开(公告)号:AU660799B2
公开(公告)日:1995-07-06
申请号:AU3988793
申请日:1993-05-28
Applicant: BASF AG
Inventor: LUBISCH WILFRED , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , A61K31/498 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/26 , C07D241/44 , C07D241/52 , C07D401/04 , C07D403/04 , C07D487/12 , C07D487/14 , C07D403/10
Abstract: Quinoxaline-2,3-(1H,4H)diones of the general formula I in which the variables have the following meaning: R is hydrogen; an aliphatic radical having up to 12 C atoms, which can carry one of the following substituents: phenyl, cyclopentyl, cyclohexyl or a group -CO-R , -CO-O-R or -CO-NH-R , where R denotes hydrogen, C1-C4-alkyl, phenyl, benzyl or 1-phenylethyl; a cycloaliphatic radical having up to 12 C atoms, or a phenyl group, where the cyclic groups contained in R can carry up to three of the following substituents: C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, halogen, nitro, cyano, -CO-O-R and -CO-NH-R ; R is a pyrrol-1-yl group which can carry up to two of the following substituents: C1-C4-alkyl, phenyl, phenylsulphonyl, nitro, cyano and one of the groups -CO-O-R , -CO-NH-R , -CH2-O-R , -O-R and -CH=NO-R ; R is identical or different radicals from the following: C1-C4-alkyl, C1-C4-alkoxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, trichloromethoxy, fluorine, chlorine, bromine, iodine, nitro, cyano and one of the groups -CO-O-R and -CO-NH-R and a fused benzene ring; n is 0 to 3. Quinoxaline-2,3-(1H,4H)diones I' in which R has the meaning mentioned. The compounds I and I' are suitable as medicines for human and veterinary medicine.
-
-
-
-
-
-
-
-
-